The implementation and side effect management of immune checkpoint inhibitors in gynecologic oncology: a JAGO/NOGGO survey

The implementation and side effect management of immune checkpoint inhibitors in gynecologic oncology: a JAGO/NOGGO survey

Abstract Background The integration of immune checkpoint inhibitors (ICIs) into routine gynecologic cancer treatment requires a thorough understanding of how to manage immune-related adverse events (irAEs) to ensure patient safety. However, reports on real-world clinical experience in the management...

Full description

Saved in:
Bibliographic Details
Main Authors: Maximilian Riedel, Helene Herrmann, Thomas Bartl, Anna-Maria Rossner, Anna Tatzber, Chiara Flethe, Dario Zocholl, Barbara Schmalfeldt, Jalid Sehouli, Klaus Pietzner
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Gynecologic oncology
Breast cancer
Immune checkpoint blockade
Immune adverse events
Online Access:https://doi.org/10.1186/s12885-025-13432-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13432-5

Similar Items